Oral Trovafloxacin vs Oral Cefuroxime ± Erythromycin in Community-Acquired Pneumonia J. Petersonthe Trovafloxacin Study Group Poster Presentations 01 December 2012 Pages: 301 - 303
Trovafloxacin vs High Dose Amoxicillin in the Treatment of Community-Acquired Bacterial Pneumonia R. Danielthe Trovafloxacin Study Group Poster Presentations 01 December 2012 Pages: 304 - 305
Trovafloxacin vs Amoxicillin/Clavulanic Acid in the Treatment of Acute Exacerbations of Chronic Obstructive Bronchitis R. Danielthe Trovafloxacin Study Group Poster Presentations 01 December 2012 Pages: 306 - 308
IV-to-Oral Switch Therapy with Trovafloxacin Compared with IV Ceftazidime/Oral Ciprofloxacin in the Treatment of Nosocomial Pneumonia H. P. BassarisD. Williams Hopkinsthe Trovafloxacin Study Group Poster Presentations 01 December 2012 Pages: 309 - 311
Trovafloxacin vs Clarithromycin in Patients with Ambulatory Community-Acquired Pneumonia D. Williams Hopkinsthe Trovafloxacin Study Group Poster Presentations 01 December 2012 Pages: 312 - 314
Trovafloxacin vs Amoxicillin in the Oral Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis R. Danielthe Trovafloxacin Study Group Poster Presentations 01 December 2012 Pages: 315 - 317
Trovafloxacin vs Ceftriaxone/Cefpodoxime ± Erythromycin in Hospitalised Community-Acquired Pneumonia D. Williams HopkinsR. Danielthe Trovafloxacin Study Group Poster Presentations 01 December 2012 Pages: 318 - 319
Oral Trovafloxacin Compared with Amoxicillin (plus Optional Erythromycin) for the Treatment of Mild to Moderate Community-Acquired Pneumonia R. Danielthe Trovafloxacin Study Group Poster Presentations 01 December 2012 Pages: 320 - 322
Trovafloxacin vs Ciprofloxacin ± Clindamycin/Metronidazole in Patients with Nosocomial Pneumonia D. Williams HopkinsR. Danielthe Trovafloxacin Study Group Poster Presentations 01 December 2012 Pages: 323 - 325
Oral Levofloxacin Compared with Clarithromycin in Acute Sinusitis B. LaskoC. Y. Lauthe Canadian Collaborative Sinusitis Study Group Poster Presentations 01 December 2012 Pages: 326 - 327
Ciprofloxacin and Cefuroxime Axetil in Acute Community-Acquired Rhinosinusitis Mark WeisKim Hendrickthe Rhinosinusitis Investigation Group Poster Presentations 01 December 2012 Pages: 328 - 329
Are the Fluoroquinolones Comparable in the Treatment of Urinary Tract Infections? Kurt G. Naber Poster Presentations 01 December 2012 Pages: 330 - 334
Effects of Ciprofloxacin in Urinary Tract Infections Using Different Dose Regimens Kazimierz Janicki Poster Presentations 01 December 2012 Pages: 335 - 338
Efficacy and Safety of Ofloxacin in Ureaplasma Infections of the Upper Urinary Tract Jordan D. DimitrakovDimiter J. DimitrakovGeorges Rawadi Poster Presentations 01 December 2012 Pages: 339 - 340
Ciprofloxacin in the Treatment of Chronic Bacterial Prostatitis Kurt G. NaberJ. Fochtthe German Prostatitis Study Group Poster Presentations 01 December 2012 Pages: 341 - 343
Activity of Moxifloxacin Against Moraxella catarrhalis and Atypicals A. Dalhoff Poster Presentations 01 December 2012 Pages: 344 - 345
The Activity of Fluoroquinolones and Other Antimicrobial Agents Against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis Clyde ThornsberryP. OgilvieD. F. Sahm Poster Presentations 01 December 2012 Pages: 346 - 348
Activity of Moxifloxacin Against H. influenzae and H. parainfluenzae A. Dalhoff Poster Presentations 01 December 2012 Pages: 349 - 350
Antipneumococcal Activity of Moxifloxacin A. Dalhoff Poster Presentations 01 December 2012 Pages: 351 - 353
Inhibition of Pneumococcal Topoisomerases by Sitafloxacin I. MorrisseyJ. T. George Poster Presentations 01 December 2012 Pages: 354 - 355
Serum Bactericidal Activity of Trovafloxacin Against Drug-Resistant Respiratory Pathogens Gary E. Stein Poster Presentations 01 December 2012 Pages: 356 - 357
Grepafloxacin Activity Against 3000 Canadian Respiratory Tract Pathogens Daryl J. HobanG. G. ZhanelJ. A. Karlowsky Poster Presentations 01 December 2012 Pages: 358 - 360
Surveillance of Antimicrobial Resistance among Respiratory Tract Pathogens in the United States, 1997 to 1998 Clyde ThornsberryMary L. HickeyDaniel F. Sahm Poster Presentations 01 December 2012 Pages: 361 - 363
International Surveillance of Susceptibility to Levofloxacin and Other Agents among Respiratory Pathogens Clyde ThornsberryM. L. HickeyD. F. Sahm Poster Presentations 01 December 2012 Pages: 364 - 365
Levofloxacin and Clarithromycin Antipneumococcal Activity Catherine L. ClarkMichael R. JacobsPeter C. Appelbaum Poster Presentations 01 December 2012 Pages: 366 - 368
Antipneumococcal Activity of Gatifloxacin by Time-Kill Methodology Gengrong LinMichael R. JacobsPeter C. Appelbaum Poster Presentations 01 December 2012 Pages: 369 - 371
Antipneumococcal Activity of Gatifloxacin by Agar Dilution MIC Dianne B. HoellmanMichael R. JacobsPeter C. Appelbaum Poster Presentations 01 December 2012 Pages: 372 - 373
Susceptibility of Respiratory Pathogens to Grepafloxacin R. CisternaM. GobernadoJulio Angel García-Rodríguez Poster Presentations 01 December 2012 Pages: 374 - 375
Bactericidal Activity of Grepafloxacin Against Respiratory Pathogens Franz DaschnerU. FrankK. Huber Poster Presentations 01 December 2012 Pages: 376 - 377
Postantibiotic Effect of Levofloxacin Against Pneumococci Sheila K. SpanglerGengrong LinPeter C. Appelbaum Poster Presentations 01 December 2012 Pages: 378 - 380
MICs for Streptococcus pneumoniae with Reduced Penicillin Susceptibility Vicki A. LunaMarilyn C. Roberts Poster Presentations 01 December 2012 Pages: 381 - 382
Development of High Level Quinolone Resistance in Streptococcus pneumoniae During Sequential Quinolone Therapy Byungse SuhBennett LorberThomas D. Gootz Poster Presentations 01 December 2012 Pages: 383 - 384
Chondrotoxicity and Target Tissue Kinetics of Ofloxacin in Immature Rats after Multiple Doses R. SchwabeEdith LozoRalf Stahlmann Poster Presentations 01 December 2012 Pages: 385 - 387
Chondrotoxicity of Ciprofloxacin in Immature Beagle Dogs R. StahlmannS. KühnerD. van Sickle Poster Presentations 01 December 2012 Pages: 388 - 389
Effects of Ofloxacin on the Ultrastructure of Achilles Tendon in Rats Mehdi ShakibaeiKerstin PfisterRalf Stahlmann Poster Presentations 01 December 2012 Pages: 390 - 392
Supplementation with Magnesium and Tocopherol Diminishes Quinolone-Induced Chondrotoxicity in Immature Rats R. StahlmannR. SchwabeJ. Vormann Poster Presentations 01 December 2012 Pages: 393 - 394
Clinical Safety Profile of Grepafloxacin H. LodeF. VogelW. Elies Poster Presentations 01 December 2012 Pages: 395 - 396
Phototoxic Potential of Gatifloxacin, a New Fluoroquinolone Antimicrobial J. FergusonJ. McEwenD. Watson Poster Presentations 01 December 2012 Pages: 397 - 399
Comparative Antimycobacterial Activity of BAY 12-8039 and Gatifloxacin Hajime Saito Poster Presentations 01 December 2012 Pages: 400 - 401
Fluoroquinolones in the Treatment of Atypical Mycobacterial Infections in AIDS M. BassettiC. BussolinoD. Bassetti Poster Presentations 01 December 2012 Pages: 402 - 403
In Vitro Activity of Grepafloxacin Against Chlamydia trachomatis F. PoutiersS. Dessus-BabusB. de Barbeyrac Poster Presentations 01 December 2012 Pages: 404 - 405
Susceptibility of Mycoplasma hominis to Moxifloxacin by E-Test and Agar Dilution Ken B. WaitesKay C. CanuppGeorge E. Kenny Poster Presentations 01 December 2012 Pages: 406 - 407
Therapeutic Effects of Sitafloxacin in Rat Uterine Endometritis Hiroshige MikamoKyoko KawazoeTeruhiko Tamaya Poster Presentations 01 December 2012 Pages: 408 - 409
Pharmacodynamics of Trovafloxacin and Ciprofloxacin Against Ciprofloxacin-Resistant Viridans Streptococci Philip D. ListerChristine C. Sanders Poster Presentations 01 December 2012 Pages: 410 - 411
Therapeutic Efficacy of Sitafloxacin Against Pseudomonas aeruginosa in a Rat Model of Urinary Tract Infection Yuichi KurosakaYoshihisa IshidaHiromi Kumon Poster Presentations 01 December 2012 Pages: 412 - 414
Quinolone Activity Against Respiratory Pathogens B. Wiedemann Poster Presentations 01 December 2012 Pages: 415 - 416
Pharmacodynamic Activity of Levofloxacin in an In Vitro Model Against Gram-Positive and Gram-Negative Bacteria B. WiedemannE. Pfeil Poster Presentations 01 December 2012 Pages: 417 - 419